These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1125 related articles for article (PubMed ID: 2918519)

  • 21. Synthesis and antitumor activity of a novel water soluble mitomycin analog; 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C.
    Kono M; Saitoh Y; Kasai M; Sato A; Shirahata K; Morimoto M; Ashizawa T
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1128-30. PubMed ID: 2766417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and antitumor activity of 7-substituted 1,2-aziridinomitosenes.
    Iyengar BS; Remers WA; Bradner WT
    J Med Chem; 1986 Oct; 29(10):1864-8. PubMed ID: 3761307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformations of complexes between mitomycins and decanucleotides. 3. Sequence specificity, binding at C-10, and mitomycin analogues.
    Remers WA; Rao SN; Wunz TP; Kollman PA
    J Med Chem; 1988 Aug; 31(8):1612-20. PubMed ID: 3397999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The derivation of 1a-demethylmitomycin G from mitomycin C.
    Kono M; Kasai M; Shirahata K; Morimoto M
    J Antibiot (Tokyo); 1990 Apr; 43(4):383-90. PubMed ID: 2112532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
    Ishizeki S; Ohtsuka M; Irinoda K; Kukita K; Nagaoka K; Nakashima T
    J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additional nucleotide derivatives of mitosenes. Synthesis and activity against parental and multidrug resistant L1210 leukemia.
    Iyengar BS; Dorr RT; Remers WA
    J Med Chem; 1991 Jul; 34(7):1947-51. PubMed ID: 1906107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH; Singh SV
    Cancer Res; 1992 Dec; 52(23):6666-70. PubMed ID: 1423311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reassignment of the structure for the antitumor agent RR-150.
    Senter PD; Langley DR; Manger WE; Vyas DM
    J Antibiot (Tokyo); 1988 Feb; 41(2):199-201. PubMed ID: 3356608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.
    Bradner WT; Rose WC; Schurig JE; Florczyk AP; Huftalen JB; Catino JJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6475-81. PubMed ID: 3933826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
    Mabel JA; Wodinsky I
    Cancer; 1983 Feb; 51(4):600-5. PubMed ID: 6401590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic acetal derivatives of mitomycin C.
    Kaneko T; Wong H; Rose WC; Bradner WT; Doyle TW
    J Antibiot (Tokyo); 1990 Jan; 43(1):122-4. PubMed ID: 2307625
    [No Abstract]   [Full Text] [Related]  

  • 33. New sugar mitomycin C analogues: preparation, murine P388 antitumor activity, and leukopenia induction.
    Talebian A; Green D; Hammer CF; McPherson E; Schein PS
    J Pharm Sci; 1990 Dec; 79(12):1105-8. PubMed ID: 2127804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogues.
    Driscoll JS; Marquez VE; Plowman J; Liu PS; Kelley JA; Barchi JJ
    J Med Chem; 1991 Nov; 34(11):3280-4. PubMed ID: 1956046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems.
    Imai R; Morimoto M; Marumo H; Kobayashi T; Tsuruo T; Inaba M; Tsukagoshi S; Sakurai Y
    Gan; 1981 Dec; 72(6):944-9. PubMed ID: 6804296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationships of new dimeric mitomycin derivatives; 7-N,7'-N'-bis(omega-thioalkyl)dimitomycins.
    Kono M; Saitoh Y; Kasai M; Shirahata K; Morimoto M; Ashizawa T
    J Antibiot (Tokyo); 1993 Sep; 46(9):1428-38. PubMed ID: 8226321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ring-hydroxylated analogues of lucanthone as antitumor agents.
    Archer S; Miller KJ; Rej R; Periana C; Fricker L
    J Med Chem; 1982 Mar; 25(3):220-7. PubMed ID: 7069701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
    Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
    Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative structure-activity relationships of colchicines against P388 leukemia in mice.
    Quinn FR; Beisler JA
    J Med Chem; 1981 Mar; 24(3):251-6. PubMed ID: 7265111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity and toxicity in animals of RR-150 (7-cysteaminomitosane), a new mitomycin derivative.
    Bradner WT; Rose WC; Schurig JE; Schlein A; Huftalen JB
    Cancer Res; 1984 Dec; 44(12 Pt 1):5619-23. PubMed ID: 6437670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.